About this trial
Liver transplant (LT) recipients with a history of alcohol-related liver disease (ALD) may encounter various psychosocial and medical challenges during post-LT recovery, even beyond the initial post-transplant period. Effective and sustainable interventions will be crucial for improving patient outcomes. This clinical trial will examine the impact of peer support specialists (PSS) on the recovery experience of individuals who received LT for ALD. The trial seeks to answer two main questions:
* Are LT recipients who work with PSS less likely to resume alcohol use or tend to drink less overall? * Do LT recipients who work with PSS engage more with recommended medical care and have better overall survival?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
English speakers
Received a liver transplant for alcohol-associated liver disease
Has 1 to 3 years of continuous alcohol abstinence at the time of trial entry
Disqualifiers
Liver transplant recipients without a history of alcohol-associated liver disease
Inability to provide informed consent
Active participation in a separate intervention trial for alcohol use disorder
Trial design
Single group
Treatments tested in this trial
Peer Support
BehavioralThe study will recruit PSS based on lived experiences with ALD/LT and interpersonal skills. The PSS will receive tailored skills training from the study team in areas such as delivering brief counseling, active listening, and maintaining confidentiality. Participants will meet regularly with a PSS between standard clinic visits throughout a one-year study period. The PSS will deliver brief counseling interventions at each session. Study investigators will meet with the PSS at scheduled intervals to review progress. Study investigators will also review up to 20% of the audio recordings of sessions between PSS and study participants to assess fidelity to the intervention protocol.
Treatment groups
Trial outcomes
Primary outcomes
Alcohol Consumption
Any use or excessive use (i.e., \>7/\>14 drinks per week for women/men) by biomarker or self-report
Secondary outcomes
Liver Transplant Medical Treatment Engagement
Proportion of kept/scheduled LT follow-up medical appointments
Overall Post-Liver Transplant Survival
All-cause mortality
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Johns Hopkins University
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator